U.S. equity futures inched upward on Monday as market participants digested an active string of corporate announcements spanning biotechnology, Bitcoin-linked miners and energy contract news.
At 08:34 ET (12:34 GMT), S&P 500 futures were up 0.1%, Nasdaq 100 futures rose 0.4%, and Dow futures advanced 0.3%.
Below are the most notable premarket stock moves:
-
Apogee Therapeutics experienced a dramatic surge, with shares jumping 47% after AbbVie agreed to acquire the biotechnology company for $10.9 billion. The transaction represents AbbVie’s largest purchase in more than five years and is positioned to expand the drugmaker’s next-generation immunology pipeline.
-
AbbVie shares rose 1.5% following the announcement of the takeover of Apogee Therapeutics as the company looks to broaden its immunology treatment portfolio and add new growth drivers.
-
BitFuFu advanced 8.2% after the Bitcoin miner disclosed a share repurchase program authorizing the buyback of up to $5 million of its Class A ordinary shares over a two-year period.
-
Nuvectis Pharma climbed 5.7% after entering a licensing agreement with Haisco Pharmaceutical Group covering exclusive ex-China rights to two clinical-stage drug candidates. The deal brings a Complement Factor B inhibitor and a BRAF inhibitor into Nuvectis’ pipeline.
-
Palvella Therapeutics increased 5% after the U.S. Food and Drug Administration granted a rolling review for its New Drug Application for QTORIN rapamycin, a drug in development for microcystic lymphatic malformations.
-
Chevron gained 1.3% following the announcement of a 20-year power purchase agreement with Microsoft. Under the pact, Chevron will supply natural gas-fired electricity to a proposed data center campus in West Texas. The project is expected to provide roughly 2.67 gigawatts of capacity and to begin supplying power in 2028.
These premarket moves reflect investor focus on corporate dealmaking and company-level strategic actions across multiple sectors. Biotech names attracted particular attention after the AbbVie-Apogee transaction brought a substantial premium to Apogee’s shares and modest gains for AbbVie. Cryptocurrency-linked equities also moved higher after a buyback program was announced by a miner, while energy and infrastructure-related news received attention following Chevron’s long-term agreement tied to a proposed data center in West Texas.
The spread of activity illustrates how single-company developments - from licensing deals and regulatory reviews to acquisitions and share repurchases - can have outsized effects on premarket sentiment and trading directions.